Ipsen Reaches Deal To Advance Precision T Cell Engagers From Marengo’s Tri-STAR Platform
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Ipsen (IPSEY) and Marengo Therapeutics Inc. have expanded their ongoing oncology research partnership, to include TriSTAR, Marengo’s next-generation, precision T cell engager or TCE technology.
:max_bytes(150000):strip_icc():format(jpeg)/INV_SP500Gainers_Losers_2023_GettyImages-1223455297-196b1bea36f64240a70a0ce37ba6d1bc.jpg "Best Times of the Day, Week, and Month to Trade Stocks")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-172751278-cd584128c8ac48bbb99887a942f07eed.jpg "Why the Prices of Sports Tickets Vary So Much")
:max_bytes(150000):strip_icc():format(jpeg)/accountspayable.asp-Final-e4e5efa448a94289b6b17189aa72f10e.jpg "Are Accounts Payable an Expense?")
:max_bytes(150000):strip_icc():format(jpeg)/index-funds-7ae7ad9cf2554db68fa0e8a6e523f41d.jpg "Investing in Index Funds: What You Need to Know")